APA (7th ed.) Citation

Gee, K. W., Olincy, A., Kanner, R., Johnson, L., Hogenkamp, D., Harris, J., . . . Freedman, R. (2017). First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288. Journal of psychopharmacology (Oxford), 31(4), 434. https://doi.org/10.1177/0269881117691590

Chicago Style (17th ed.) Citation

Gee, Kelvin W., et al. "First in Human Trial of a Type I Positive Allosteric Modulator of Alpha7-nicotinic Acetylcholine Receptors: Pharmacokinetics, Safety, and Evidence for Neurocognitive Effect of AVL-3288." Journal of Psychopharmacology (Oxford) 31, no. 4 (2017): 434. https://doi.org/10.1177/0269881117691590.

MLA (9th ed.) Citation

Gee, Kelvin W., et al. "First in Human Trial of a Type I Positive Allosteric Modulator of Alpha7-nicotinic Acetylcholine Receptors: Pharmacokinetics, Safety, and Evidence for Neurocognitive Effect of AVL-3288." Journal of Psychopharmacology (Oxford), vol. 31, no. 4, 2017, p. 434, https://doi.org/10.1177/0269881117691590.